Esteban Daudén

17PUBLICATIONS
76CO-AUTHORS
Molecular targetsPacific Peoples theory of change models for healthPharmacogenomicsCardiology (incl. cardiovascular diseases)Counselling, wellbeing and community services
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 14, 2026
Treatment-associated phenotype switching between psoriasis and atopic dermatitis.

|Jul 18, 2025
Well-Being in Psoriasis: Weighting its Components Using Best-worst Scaling Methodology.

Esteban Daudén, Isabel Belinchón, Elena Colominas-González

|May 19, 2025
Risk of adverse events of psoriasis treatment with biologic agents and new small molecules-BIOBADADERM Registry.

María Olivares-Guerrero, Esteban Daudén, Josep Riera-Monroig

|Apr 30, 2025
Cardiovascular safety of systemic psoriasis treatments: A prospective cohort study in the BIOBADADERM registry.

Juan José Lluch-Galcerá, José Manuel Carrascosa, Alicia González-Quesada

|Jun 24, 2024
Defining well-being in psoriasis: A Delphi consensus among healthcare professionals and patients.

Esteban Daudén, I Belinchón, E Colominas-González

|Jun 11, 2024
Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort study.

Andrea Chiricozzi, Giulia Coscarella, Luis Puig

Pageof 3